PJOQX | VIVAX | PJOQX / VIVAX | |
Total Expense Ratio | 0.75 | 0.17 | 441% |
Annual Report Gross Expense Ratio | 1.04 | 0.17 | 612% |
Fund Existence | 11 years | 33 years | - |
Gain YTD | 7.437 | 6.724 | 111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 280M | 195B | 0% |
Annual Yield % from dividends | 1.11 | 2.06 | 54% |
Returns for 1 year | 7.75 | 9.76 | 79% |
Returns for 3 years | 37.48 | 34.31 | 109% |
Returns for 5 years | 63.09 | 74.87 | 84% |
Returns for 10 years | 16.70 | 116.32 | 14% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CAVYX | 17.11 | 0.06 | +0.35% |
SEI Catholic Values Equity Y (SCVT) | |||
CTHRX | 106.22 | 0.25 | +0.24% |
Columbia Global Technology Growth Inst2 | |||
TQGIX | 20.27 | 0.04 | +0.20% |
T. Rowe Price Integrated Global Eq I | |||
ETCHX | 30.48 | -0.02 | -0.07% |
Eventide Healthcare & Life Sciences C | |||
FEPUX | 61.46 | -0.32 | -0.52% |
American Funds EUPAC 529-F-3 |